3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
9
Neoplasms
6
Cancer Pain
5
Marijuana Abuse
2
Signs and Symptoms
1
Parasomnias
1
Neuralgia
1
Nausea
1
Multiple Sclerosis
1
Marijuana Use
1
Diabetes Mellitus
1
Anxiety Disorders
1
1- Cancer Patients During Chemotherapy Treatment
1
Interventions
Dexamethasone
22
Ondansetron
20
Aprepitant
20
Palonosetron
17
Granisetron
11
Calcium Dobesilate
8
Therapeutics
7
Olanzapine
6
dexamethasone acetate
5
Doxorubicin
5
Cyclophosphamide
5
casopitant
4
Acupressure
4
netupitant
3
dolasetron
3
Yoga
3
Vincristine
3
Radiotherapy
3
Dronabinol
3
Analgesia
3
ginger extract
2
fosaprepitant
2
dexamethasone 21-phosphate
2
Tropisetron
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Prochlorperazine
2
Metoclopramide
2
Mesna
2
Ifosfamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Nausea
×
nabiximols
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled